1 Subjects: “...Biological Products / therapeutic use...”

2 Subjects: “...Biological Products / therapeutic use...”

3 “... from a producer / supplier of medical equipment. The issue was whether it would be advisable to use...”

4 “... at Norwegian hospitals (50,000 units per year) is the plasma product Octaplas(r). Each unit (200 mL) contains a...”

5 “... such as employees' function, productivity, absense, disability, sick-leave, costs and adverse events. The included...”

6 “... reduction in patients' social functioning and workplace productivity. The mainstays of treatment are various...”

7 “... treatment and the work-related productivity costs due to disease are included, the catch-up vaccine is cost...”

8

9

10 “... per year. The European Network for Health Technology Assessment (EUnetHTA) produces collaborative...”

11 “... in some harmful constituents of snuff products sold in Scandinavia and USA. Main results A systematic...”

12 “.... This review demonstrates that a significant body of research has failed to produce a clear answer to key...”

13 “... to produce clinical practice guidelines or health technology assessments or organisations to support the use...”

14 “... in psychological distress after PD, but none of the studies were sufficiently methodologically robust to produce...”

15 “... pharmacologically produced), acupuncture, reflexology, massage, aromatherapy, hypnosis, homeopathy, traditional...”

16

17

18

19

20